Merck Operating Income 2012-2026 | MRK

Merck operating income for the twelve months ending March 31, 2026 was $12.970B, a 36.42% decline year-over-year.

  • Merck annual operating income for 2025 was $22.107B, a 9.33% increase from 2024.
  • Merck annual operating income for 2024 was $20.221B, a 584.53% increase from 2023.
  • Merck annual operating income for 2023 was $2.954B, a 83.84% decline from 2022.

Merck Operating Income 2012-2026 | MRK

  • Merck annual operating income for 2025 was $22.107B, a 9.33% increase from 2024.
  • Merck annual operating income for 2024 was $20.221B, a 584.53% increase from 2023.
  • Merck annual operating income for 2023 was $2.954B, a 83.84% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B